Notice of AGM

RNS Number : 0578I

Hutchison China Meditech Limited

23 March 2015

 

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

2014 Annual Report and

Notice of Annual General Meeting

London: Monday, 23 March 2015: Chi-Med today announces that its 2014 Annual Report together with the Notice of Annual General Meeting and the Proxy Form have been posted to shareholders.  The documents can be accessed from the website of Chi-Med (www.chi-med.com).

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone:     [phone]
Panmure Gordon (UK) Limited	Telephone:     [phone]
Richard Gray Andrew Potts
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone:     [phone] Mobile:           [phone] Mobile:           [phone]

 

About Chi-Med

Chi-Med is a China-based healthcare group focused on researching, developing, manufacturing and selling pharmaceuticals and health-related consumer products.  Its Drug R&D Division focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases.  Its China Healthcare Division manufactures, markets and distributes prescription and over-the-counter pharmaceuticals in China.  Its emerging Consumer Products Division focuses on organic and natural consumer products in Asia.

Chi-Med is majority owned by the multinational conglomerate Hutchison Whampoa Limited (SEHK:13).  For more information, please visit: www.chi-med.com.

 

END

 

 

NOASELFESFISEDD